European Parliament Edges Closer To Adopting MDR Transition Proposal
Executive Summary
The European Parliament voted in favor of using an accelerated process to adopt the European Commission’s proposed extension timelines for legacy devices in the context of the Medical Device Regulation and the removal of the “sell-off” date, which also applies to some IVDs.
You may also be interested in...
MDR Amendment Proposal Likely To Be Adopted In Two Weeks’ Time
Amending the MDR to stem the flow of medtech products being withdrawn from the market has long been seen as urgent. It looks like the EU is keeping its foot on the accelerator to adopt its latest proposal despite concerns raised about the text.
Commenting On the EU MDR Proposal? What You Need To Know About Finer Details
18 January is the deadline to respond to the European Commission’s 6 January proposal to amend the Medical Device Regulation by extending legacy product transition deadlines. This article explains how changes are expected to be made.
EU Orphan Drug Law Reform Will See Innovation Drop By 12%, Industry Warns
The European Commission’s proposals to overhaul the EU pharma legislation, which will see some orphan drug incentives cut, would cause a “significant dip in innovation,” according to number crunching from pharma industry association EFPIA.